
Healthcare Hires of Note
Read about executive hires across healthcare and life science companies and organizations such as ProofPilot, Genentech, MassBio, Virgin Pulse, and more.
Read about executive hires across healthcare and life science companies and organizations such as ProofPilot, Genentech, MassBio, Virgin Pulse, and more.
The French delegation at BIO on June 13-16 has a compelling story to tell about biopharma and medtech growth and investment in France and the U.S. Here's a preview of some of the companies that will be at the convention, events they will host and why you should check them out.
As artificial intelligence becomes more focused and efficient, and the pharmaceutical and biotech industries consolidate to survive, it’s important to also reflect on what is working in the fight against Covid-19. This will help us to be more prepared for the next global health crisis.
Read about news from Equiva, DNA Script, Healthmine, Infermedica, and more.
Read news from Carrum Health, Healthmine, 1upHealth, and more.
Read about new developments from HealthMine, TailorMed, Heru and Entos.
Read news from healthcare and life science companies including HealthMine, Zus Health, Sema4 and more.
Read about new developments from Stellar Health, Paige, venBio, and more.
Read about new developments from Blue Therapeutics, Docbot, Sema4, and Deep Lens.
The five life sciences IPOs this week continues the steady march companies are making to the public markets this year. This week's activity follows a first quarter that Renaissance Capital calculates was the busiest for newly public companies since 2000. Healthcare IPOs continued to dominate the stock offerings.
In response to emailed questions, the CEO and CTO talk about the immune intelligence startup's Human Immunity Map — a growing database of immune interactions that can support the development of multiplex diagnostics, vaccines and therapeutics.
Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen talked about the formation of the company and its goal to make stem cell therapies accessible for patients.
More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies— publicly-traded shell companies created with the purpose of taking a private company public. But as the number of SPACs searching for targets increases, will the SPAC bubble burst?
Check out new developments from healthcare startups including Bind, ChromaCode and more.
Read about new developments and milestones in the journey of healthcare startups from Truvian Sciences, NeuroFlow and more.